Ataxia UK

SW9 6DE (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£372,376

Apr 09 - Apr 12

Applying epigenetic modifying drugs to treat Friedreich's Ataxia

MRC award to Medical Research Council and Richard Festenstein

£691,269

Feb 13 - Aug 16

Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis - The International IBM Consortium Genetic Study

MRC award to University College London and Henry Houlden

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}